Month: August 2013
GAINing Ground in Antibiotics
With the rise of antibiotic resistant “superbugs” in recent years, everyone agrees there is an …
When Crop Vandalism Kills Children...
In the days following the senseless destruction of Golden Rice field trials in the Philippines …
Chinese In-Licensing Continues to Strengthen
Chinese companies are eager to collaborate with their ex-China counterparts, and in-licensing agreements are outpacing …
Fresenius v. Baxter: BIO files Amicus Brief in Federal Circuit
The Biotechnology Industry Organization filed an amicus brief at the Federal Circuit in the case …
BIO Investor Forum Company Snapshot: MAX BioPharma
Earlier this week, we featured a presenting company for our upcoming BIO Investor Forum event …
TTIP: Global Regulatory Cooperation and Convergence
The Transatlantic Trade and Investment Partnership (TTIP) initiative holds tremendous promise for the long-term competitiveness …
CSBI: New Study Outlines Potential Impact of Three Promising Tax Proposals
Ernst & Young recently released a study to determine the potential impact of three tax …
FDA Issues Final Guidance on Clinical Trial Oversight
The FDA released its final guidance governing clinical trial oversight and urges a risk-based approach …
BIO Investor Forum Company Snapshot: AM-Pharma
The BIO Investor Forum will be taking place this October in San Francisco for its …
Back to School: Time for Immunization Check-In
Preparing for school means gathering supplies and backpacks. It is also the perfect time to …